Clinical Trial Update: Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial comparing artesunate plus sulfadoxine-pyrimethamine against chloroquine for vivax malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Artesunate (artesunate)
• Chloroquine (chloroquine)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Vivax | Phase 2 | Status: COMPLETED